Navigation Links
MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution
Date:10/7/2009

CARLSBAD, Calif., Oct. 7 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of a groundbreaking new product, LifeGuard Soil Preservation Solution, for microbial RNA stabilization in soil samples upon collection. LifeGuard solution will enable researchers to collect soil samples in remote locations without RNA degradation or changes in transcript levels during transport to the laboratory for microbial community analysis and metagenomics.

LifeGuard Soil Preservation Solution is the first product optimized specifically to protect microbial RNA in soil and sediment samples. Virtually all research on environmental samples involves sample collection in locations that are far from a laboratory. Without special handling, the RNA levels in these samples will be altered during transport resulting in unreliable data. LifeGuard Solution puts microbes into stasis immediately upon contact and keeps the sample stable at ambient temperature during transport, resulting in reliable data and enabling the analysis of microbial interactions via RNA.

LifeGuard Soil Preservation Solution is available now. For more information visit the MO BIO website (www.mobio.com) or call 800-606-6246 to order.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in Molecular Biology since 1993. A global leader in solutions for soil, water and microbial nucleic acid purification, MO BIO's Power® kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For samples that do not require inhibitor removal, MO BIO's UltraClean® line includes optimized products for DNA and RNA isolation from a variety of sample types. Also for clinical samples, the BiOstic(TM) kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.

SOURCE MO BIO Laboratories, Inc.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
2. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
3. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. Provide an Update on the Aclidinium Bromide Clinical Development Program
4. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
5. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
6. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
7. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
8. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
9. AMICAS Launches Major New Version of Radiology Information System at RBMA 2009
10. PARI Respiratory Launches PEP S
11. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven one- ...
(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
Breaking Medicine News(10 mins):